miércoles, 12 de noviembre de 2025

Oral vaccine for norovirus shows promise in Phase 1b trial Vaxart’s orally administered vaccine tablet was safe and elicited mucosal immunity in older adults.

https://www.drugdiscoverynews.com/oral-vaccine-for-norovirus-shows-promise-in-phase-1b-trial-16318?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-_kb9juCkWeIp2VO-J_xRhOd1iNYZISqs_A2u6OjzGMbHjgpbgZ_0MIbJ5dfnwp4wicH992PNGJFHALuBx0V6qQLcKtJw&_hsmi=389580236&utm_content=389580236&utm_source=hs_email

No hay comentarios:

Publicar un comentario